Cardlytics, Inc. (CDLX) DCF Valuation

Cardlytics, Inc. (CDLX) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Cardlytics, Inc. (CDLX) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Evaluate Cardlytics, Inc.'s (CDLX) financial outlook like an expert! This (CDLX) DCF Calculator provides pre-filled financial information along with the flexibility to modify revenue growth, WACC, margins, and other crucial assumptions to align with your projections.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 210.4 186.9 267.1 298.5 309.2 345.6 386.3 431.7 482.5 539.3
Revenue Growth, % 0 -11.19 42.93 11.76 3.57 11.77 11.77 11.77 11.77 11.77
EBITDA -12.8 -39.5 -89.9 -419.0 -99.0 -133.3 -149.0 -166.6 -186.2 -208.1
EBITDA, % -6.08 -21.14 -33.66 -140.34 -32.02 -38.58 -38.58 -38.58 -38.58 -38.58
Depreciation 7.4 12.4 33.7 43.7 29.5 32.5 36.3 40.6 45.3 50.7
Depreciation, % 3.52 6.65 12.6 14.65 9.55 9.39 9.39 9.39 9.39 9.39
EBIT -20.2 -51.9 -123.6 -462.7 -128.5 -155.7 -174.0 -194.5 -217.3 -242.9
EBIT, % -9.6 -27.79 -46.26 -154.99 -41.56 -45.04 -45.04 -45.04 -45.04 -45.04
Total Cash 104.5 293.2 233.5 121.9 91.8 212.6 237.6 265.6 296.8 331.8
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 85.4 86.6 117.2 120.1 126.0
Account Receivables, % 40.56 46.31 43.87 40.22 40.75
Inventories .1 .1 .1 .1 .0 .1 .1 .2 .2 .2
Inventories, % 0.06130305 0.05885752 0.03556507 0.0267969 0 0.03650451 0.03650451 0.03650451 0.03650451 0.03650451
Accounts Payable 1.2 1.4 4.6 3.8 4.4 4.0 4.4 5.0 5.5 6.2
Accounts Payable, % 0.58404 0.7293 1.73 1.26 1.43 1.15 1.15 1.15 1.15 1.15
Capital Expenditure -11.0 -10.1 -12.6 -13.5 -12.4 -16.5 -18.4 -20.6 -23.0 -25.8
Capital Expenditure, % -5.24 -5.41 -4.7 -4.52 -4.01 -4.78 -4.78 -4.78 -4.78 -4.78
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -20.8 -54.8 -116.4 -461.3 -128.5 -153.8 -171.9 -192.1 -214.7 -240.0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -108.7 -53.5 -122.7 -434.8 -116.6 -158.7 -170.8 -190.9 -213.4 -238.5
WACC, % 7.03 7.03 6.86 7.03 7.03 7 7 7 7 7
PV UFCF
SUM PV UFCF -786.2
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -243
Terminal Value -4,867
Present Terminal Value -3,470
Enterprise Value -4,256
Net Debt 174
Equity Value -4,431
Diluted Shares Outstanding, MM 36
Equity Value Per Share -121.43

What You Will Get

  • Real CDLX Financial Data: Pre-filled with Cardlytics’ historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See Cardlytics’ intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • 🔍 Real-Life CDLX Financials: Pre-filled historical and projected data for Cardlytics, Inc.
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Cardlytics’ intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Cardlytics’ valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered Cardlytics data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for Cardlytics’ intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose This Calculator for Cardlytics, Inc. (CDLX)?

  • Accuracy: Utilizes real Cardlytics financial data for precise calculations.
  • Flexibility: Tailored for users to easily adjust and test various inputs.
  • Time-Saving: Eliminate the need to create a DCF model from the ground up.
  • Professional-Grade: Crafted with the expertise and usability expected at the CFO level.
  • User-Friendly: Intuitive design allows even novices to navigate financial modeling effortlessly.

Who Should Use Cardlytics, Inc. (CDLX)?

  • Marketers: Leverage advanced analytics to optimize advertising strategies and drive customer engagement.
  • Data Analysts: Utilize robust data insights to enhance campaign performance and ROI.
  • Business Strategists: Adapt the platform to create tailored reports for stakeholders and decision-makers.
  • Finance Professionals: Gain a deeper understanding of consumer behavior and market trends through actionable data.
  • Students and Educators: Employ it as a hands-on resource for learning about digital marketing and analytics.

What the Template Contains

  • Comprehensive DCF Model: Editable template with detailed valuation calculations tailored for Cardlytics, Inc. (CDLX).
  • Real-World Data: Cardlytics' historical and projected financials preloaded for analysis.
  • Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to test various scenarios.
  • Financial Statements: Full annual and quarterly breakdowns for deeper insights into Cardlytics' performance.
  • Key Ratios: Built-in analysis for profitability, efficiency, and leverage specific to Cardlytics, Inc. (CDLX).
  • Dashboard with Visual Outputs: Charts and tables for clear, actionable results related to Cardlytics, Inc. (CDLX).

No products were found matching.